Dolutegravir and lamivudine for maintenance of HIV viral suppression in adults with and without historical resistance to lamivudine: 48 weeks results of a pilot clinical trial (TRAPRO)

Thumbnail Image
Identifiers
URI: http://hdl.handle.net/11268/8585
DOI: 10.1016/j.ebiom.2020.102779

Publication date

2019

Authors

Rial, Diego
Miguel, Rosa de
Domínguez Domínguez, Lourdes
Montejerano, R.
Esteban Cantos, Andrés

Advisors

Editors

Journal Title

Journal ISSN

Volume Title

Publisher

Metrics

Google Scholar

Research Projects

Organizational Units

Journal Issue

Abstract

Description

UNESCO Subjects

Sida
Farmacología

Keywords

Bibliographic reference

Rial-Crestelo, D., de Miguel Buckley, R., Domínguez Domínguez, L., Montejerano, R., Esteban, A., Bisbal, O., Hernando Jerez, M. A., …Arribas, J. R. (2019). Dolutegravir and lamivudine for maintenance of HIV viral suppression in adults with and without historical resistance to lamivudine: 48 weeks results of a pilot clinical trial (TRAPRO). Enfermedades Infecciosas y Microbiología Clínica, 37(especial), 81-82. https://doi.org/10.1016/j.ebiom.2020.102779

Type of document

conference poster

Collections

Área de Ciencias de la Salud